Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury

TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury

(2012) Sergio Duarte et al.   HEPATOLOGY

Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury

(2012) Patrizia Loi et al.   HEPATOLOGY

Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+T cells

(2012) Sandra Pommey et al.   HEPATOLOGY

MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma

(2012) Meng-Jie Feng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation

(2011) Y. Zhai et al.   AMERICAN JOURNAL OF TRANSPLANTATION

TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells

(2011) M. Iyori et al.   JOURNAL OF IMMUNOLOGY

Innate or Adaptive Immunity? The Example of Natural Killer Cells

(2011) E. Vivier et al.   SCIENCE

Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation

(2010) Young S. Cho et al.   IMMUNOLOGY

Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice

(2009) Guido Beldi et al.   HEPATOLOGY

Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage

(2009) Naiara Beraza et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies

(2008) Karine Crozat et al.   IMMUNOLOGICAL REVIEWS

Unknown

(2008) Andrew Vardanian et al.   MOLECULAR MEDICINE

Natural killer cells: diversity in search of a niche

(2008) James P Di Santo   NATURE IMMUNOLOGY

Functions of natural killer cells

(2008) Eric Vivier et al.   NATURE IMMUNOLOGY

Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury

(2007) R Mota et al.   BRITISH JOURNAL OF PHARMACOLOGY